Mechanisms regulating the loss of Tregs in HUPO mice that develop spontaneous inflammatory arthritis

T regulatory cells (Tregs) are a potential therapeutic target in many autoimmune diseases including rheumatoid arthritis (RA). The mechanisms responsible for the maintenance of Tregs in chronic inflammatory conditions such as RA are poorly understood. We employed our mouse model of RA in which, the following dele-tion of Flice-like inhibitory protein in CD11c(+) cells, CD11c-FLIP-KO (HUPO) mice develop spontaneous, progressive, erosive arthritis, with reduced Tregs, and the adoptive transfer of Tregs ameliorates the arthritis. HUPO thymic Treg development was normal, but peripheral of Treg Foxp3 was diminished mediated by reduction of dendritic cells and interleukin-2 (IL-2). During chronic inflamma-tory arthritis Tregs fail to maintain Foxp3, leading to non-apoptotic cell death and conversion to CD4(+)CD25(+)Foxp3(-) cells. Treatment with IL-2 increased Tregs and ameliorated the arthritis. In summary, reduced dendritic cells and IL-2 in the milieu of chronic inflammation, contribute to Treg instability, promoting HUPO arthritis progression, and suggesting a therapeutic approach in RA.

Automated summary

Tregs are a potential therapeutic target in autoimmune diseases such as rheumatoid arthritis. However, the mechanisms responsible for maintaining Tregs in chronic inflammatory conditions are poorly understood.